Authors

• Shengxiang Rao (ORCID: https://orcid.org/0000-0001-7722-8327)
• Danlan Lian (ORCID: https://orcid.org/0009-0007-2650-9357)
• Jianjun Zhou (ORCID: https://orcid.org/0000-0001-7344-6108)
• Xiaobo Qu (ORCID: https://orcid.org/0000-0003-0973-3756)
• Jiefeng Guo
• Yuqin Ding (ORCID: https://orcid.org/0000-0003-3511-4705)
• Weifeng Lin (ORCID: https://orcid.org/0000-0001-8330-7072)
• Lianting Zhong
• Ying Zhang (ORCID: https://orcid.org/0000-0001-5476-1524)

Institutions

• Sun Yat-sen University (CN)
• Xiamen University (CN)
• Fudan University (CN)
• Zhongshan Hospital of Xiamen University (CN)
• Zhongshan Hospital (CN)
• The First Affiliated Hospital, Sun Yat-sen University (CN)
• Shanghai Institute of Hematology (CN)
• Xiamen University of Technology (CN)

Publication Details

Journal

Discover Oncology

Published

2025-05-19

DOI

https://doi.org/10.1007/s12672-025-02609-w

Primary Topic

Renal cell carcinoma treatment

Type

article

Field-Weighted Citation Impact

0.00

Funders

• National Natural Science Foundation of China